Connect Sign In
While many companies are laying off or furloughing employees due to the COVID-19 pandemic, ARUP is experiencing a hiring surge as the company continues to expand its COVID-19 testing capacity.
Kimberly Hanson, MD, ARUP section chief of clinical microbiology and an associate professor at the University of Utah School of Medicine, led a study of serum (1-3)- β-D
When one of the University of Utah’s (U of U’s) AirMed helicopters take off on an emergency call, there is now a small cooler onboard containing their latest means of saving lives — blood.
Karl Voelkerding, MD, FCAP, retired from his position as medical director of genomics and bioinformatics at ARUP on July 1, 2020. Karl Voelkerding, MD, FCAP, once imagined practicing medicine as a primary care physician in a rural setting. Instead, Voelkerding would become one the world’s leading experts in NGS.
ARUP implemented numerous safety protocols when the pandemic began. Now, as cases of COVID-19 surge, the company is facing new challenges in preventing the spread of the virus among its employees.
ARUP Laboratories’ Tracy George, MD, an internationally recognized expert on mast cell disorders, was recently appointed president of the International Society for Laboratory Hematology (ISLH).
Noriko Kusukawa, PhD, retired July 2 from her position as ARUP Laboratories vice president of innovation and strategic investments after 20 years with the company.
When hospitals began postponing elective surgeries, directors of pathology training programs scrambled to adapt so that residents and fellows could still receive the instruction they needed.
Carl Wittwer, MD, PhD, and Noriko Kusukawa, PhD, who is Wittwer’s wife, are retiring from ARUP Laboratories to move to Maine, where they are building a home with a fully equipped molecular laboratory.
SALT LAKE CITY – ARUP Laboratories today announced the retirements of two pioneering scientists whose work is responsible for important advancements in laboratory medicine.<
Just 1% of residents in four Utah counties have antibodies to SARS-CoV-2, a prevalence rate below that of many other communities in the U.S., according to preliminary results of the Utah HERO project.
Lauren Pearson, DO, MPH, is the new CLIA laboratory director for ARUP at University of Utah Health and at the Huntsman Cancer Institute.
SALT LAKE CITY — ARUP
